does tirzepatide cause vision changes Ozempic and loss: GLP-1 drugs may double risk of eye disease Researchers Find Small Increased Risk

Our findings show evidence that semaglutide treatment in patients with diabetes appears to protect from vascular dementia and other dementia, but not frontotemporal or Lewy body dementia, Xu explained

Pick a day from our LIVESTREAM schedule & register for the class

So, we dive into your health history, your struggles, and your victories

According to Kumar, she is taking the right actions

- - - A new Oxford meta-analysis (P04.009, EASO 2025) confirms what many clinicians have observed: stopping GLP-1 receptor agonists often leads to rapid and near-complete weight regain within 12 years

Athletes and active adults experience faster recovery between training sessions